...
首页> 外文期刊>Vaccine >The public health value of vaccination for seniors in Europe
【24h】

The public health value of vaccination for seniors in Europe

机译:欧洲老年人疫苗接种的公共卫生价值

获取原文
获取原文并翻译 | 示例
           

摘要

Longer life expectancy and decreasing fertility rates mean that the proportion of older people is continually increasing worldwide, and particularly in Europe. Ageing is associated with an increase in the risk and severity of infectious diseases. These diseases are also more difficult to diagnose and manage in seniors who often have at least one comorbid condition (60% of seniors have two or more conditions). Infectious diseases increase the risk of hospitalization, loss of autonomy and death in seniors. Effective vaccines are available in Europe for infectious diseases such as influenza, pneumococcal diseases, herpes zoster, diphtheria, tetanus and pertussis. Their effectiveness has been demonstrated in terms of reducing the rates of hospitalization, disability, dependency and death. The prevention of diseases in seniors also results in savings in healthcare and societal costs each year in Europe. Despite the availability of vaccines, vaccine-preventable diseases affect millions of European citizens annually, with the greatest burden of disease occurring in seniors, and the medical and economic benefits associated with are not being achieved. Vaccination coverage rates must be improved to achieve the full benefits of vaccination of seniors in Europe. (C) 2018 Elsevier Ltd. All rights reserved.
机译:寿命更长,衰退的生育率意味着老年人的比例在全球范围内不断增加,特别是在欧洲。老龄化与传染病的风险和严重程度的增加有关。这些疾病也更难以诊断和管理,在往往至少有一个共用病症的老年人(60%的老年人有两个或更多条件)。传染病增加了住院的风险,老年人的自治和自主死亡。欧洲有效疫苗可用于传染病,如流感,肺炎球菌疾病,疱疹,斑鸠,喉疱疹,破伤风和百日咳等。在降低住院病,残疾,依赖和死亡的率方面已经证明了它们的有效性。预防老年人的疾病也会导致每年在欧洲每年节省医疗保健和社会费用。尽管有疫苗可用性,但疫苗可预防的疾病每年影响数百万欧洲公民,在老年人中发生的疾病负担最大,而且没有实现相关的医疗和经济效益。必须改进疫苗接种覆盖率,以实现欧洲老年人疫苗接种的充分利益。 (c)2018年elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号